Actively Recruiting
Low-cost Imaging Technology for Global Prevention of Cervical Cancer
Led by Barretos Cancer Hospital · Updated on 2025-02-06
1060
Participants Needed
2
Research Sites
219 weeks
Total Duration
On this page
Sponsors
B
Barretos Cancer Hospital
Lead Sponsor
W
William Marsh Rice University
Collaborating Sponsor
AI-Summary
What this Trial Is About
Cervical cancer remains the first or second leading cause of cancer death among women in many low-and middle-income countries. Cervical cancer prevention programs in low-resource settings are hampered by a lack of personnel with appropriate clinical expertise, lack of pathology services, and lack of associated infrastructure. There is an urgent need for appropriate diagnostic tools to enable accurate screening and diagnosis in low-resource settings. The purpose of this study is to develop and validate a low-cost Multimodal Mobile Colposcope (MMC) for global cervical cancer prevention programs. This new device will combine the imaging capabilities of a mobile colposcope with the microscopic imaging capabilities of a fiber-optic confocal imaging probe.
CONDITIONS
Official Title
Low-cost Imaging Technology for Global Prevention of Cervical Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Women >25 years of age
- Women undergoing colposcopy due to abnormal cervical screening or follow-up for a history of dysplasia
- Women of childbearing potential must have a negative urine or blood pregnancy test
- Ability to understand and willingness to provide informed consent by signing specific Informed Consent Document
You will not qualify if you...
- Women under 25 years of age
- Women who have undergone hysterectomy with removal of the cervix
- Women with known allergy to proflavine or acriflavine
- Women who are pregnant or nursing at the time of enrollment
- Incapacitated women or in vulnerable situations or who are not willing to give consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Irmandade Santa Casa de Misericórdia de Porto Alegre
Porto Alegre, Rio Grande do Sul, Brazil, 90020-090
Actively Recruiting
2
Barretos Cancer Hospital
Barretos, São Paulo, Brazil, 14784-400
Actively Recruiting
Research Team
J
Júlio César P Resende, MD, PhD
CONTACT
M
Mila P Salcedo, MD, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
PREVENTION
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here